Publications:477
- Mount Sinai Doctors
Girish N Nadkarni, MD
Nephrology
No Patient Experience Ratings
About Me
Girish N. Nadkarni, MD, MPH, is the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. As an expert physician-scientist, Dr. Nadkarni bridges the gap between comprehensive clinical care and innovative research. He is the System Chief of the Division of Data Driven and Digital Medicine (D3M), the Co-Director of the Mount Sinai Clinical Intelligence Center (MSCIC) and the Director of Charles Bronfman Institute for Personalized Medicine.
Before completing his medical degree at one of the top-ranked medical colleges in India, Dr. Nadkarni received training in mathematics. He then received a master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health, and then was a research associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in internal medicine and his clinical fellowship in nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in personalized medicine and informatics.
Dr. Nadkarni has authored more than 240 peer-reviewed scientific publications, including articles in the New England Journal of Medicine, the Journal of the American Medical Association, the Annals of Internal Medicine and Nature Medicine. Dr. Nadkarni is the principal or co-investigator for several grants funded by the National Institutes of Health focusing on informatics, data science, and precision medicine. He is also one of the multiple principal investigators of the NIH RECOVER consortium focusing on the long-term sequelae of COVID-19. He has several patents and is also the scientific co-founder of investor-backed companies—one of which, Renalytix, is listed on NASDAQ. In recognition of his work as an active clinician and investigator, he has received several awards and honors, including the Dr. Harold and Golden Lamport Research Award, the Deal of the Year award from Mount Sinai Innovation Partners, the Carl Nacht Memorial Lecture, and the Rising Star Award from ANIO.
Learn more about Kidney Health in Dr. Nadkarni's Metro.us article.
Learn more about Dr. Nadkarni's work in the Mount Sinai Newsroom.
Language
English
Position
PROFESSOR & CHAIR | Artificial Intelligence and Human Health, PROFESSOR | Medicine, Nephrology, PROFESSOR | Urology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Research Topics
Bioinformatics, Biostatistics, Cardiovascular, Genetics, Mathematical and Computational Biology, SARS Virus
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS], Immunology [IMM], Neuroscience [NEU]
Clinical Focus
- Chronic Renal Failure
- Dialysis
- Glomerulonephritis
- Hematuria
- High Blood Pressure
- Hypertension (High Blood Pressure)
- Kidney Biopsy
- Kidney Failure
- Malignant Hypertension
- Renal Ultrasound
Video
Education
MD, Rutgers Biomedical & Health Sciences
MPH, Johns Hopkins Bloomberg School of Public Health
Residency, Internal Medicine
Icahn School of Medicine at Mount Sinai West
Fellowship, Nephrology
Mount Sinai Hospital
Certifications
American Board of Internal Medicine
Awards
2014
Distinguished Paper Award
American Medical Informatics Association
2013
Best Abstract-Kidney Week
American Society of Nephrology
2012
Outstanding Senior Resident-Department of Medicine
St Lukes Roosevelt Hospital Center at Mount Sinai
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- A distributional reinforcement learning model for optimal glucose control after cardiac surgery. Jacob M. Desman, Zhang Wei Hong, Moein Sabounchi, Ashwin S. Sawant, Jaskirat Gill, Ana C. Costa, Gagan Kumar, Rajeev Sharma, Arpeta Gupta, Paul McCarthy, Veena Nandwani, Doug Powell, Alexandra Carideo, Donnie Goodwin, Sanam Ahmed, Umesh Gidwani, Matthew A. Levin, Robin Varghese, Farzan Filsoufi, Robert Freeman, Avniel Shetreat-Klein, Alexander W. Charney, Ira Hofer, Lili Chan, David Reich, Patricia Kovatch, Roopa Kohli-Seth, Monica Kraft, Pulkit Agrawal, John A. Kellum, Girish N. Nadkarni, Ankit Sakhuja. npj Digital Medicine
- Evaluating and addressing demographic disparities in medical large language models: a systematic review. Mahmud Omar, Vera Sorin, Reem Agbareia, Donald U. Apakama, Ali Soroush, Ankit Sakhuja, Robert Freeman, Carol R. Horowitz, Lynne D. Richardson, Girish N. Nadkarni, Eyal Klang. International Journal for Equity in Health
- Integrated visual and text-based analysis of ophthalmology clinical cases using a large language model. Vera Sorin, Noa Kapelushnik, Idan Hecht, Ofira Zloto, Benjamin S. Glicksberg, Hila Bufman, Adva Livne, Yiftach Barash, Girish N. Nadkarni, Eyal Klang. Scientific Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Nadkarni during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Glaxosmithkline
- Renalytix AI, Inc
- Data2Wisdom LLC
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Verici Dx
- Renalytix AI, Inc
Founder/Co-Founder/Partner
- Renalytix AI, Inc
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.